Organogenesis Holdings Inc reports results for the quarter ended in June - Earnings Summary

Organogenesis Holdings

09/08/2023 22:47

* Organogenesis Holdings Inc  ORGO.OQ  reported quarterly
adjusted
earnings of 4 cents​​ per share for the quarter ended in June.
The mean expectation of two analysts for the quarter was
for earnings of 3 cents per share.
    * Revenue fell 3.4% to $117.32 million from a year ago;
analysts
expected $115.10 million. 
    * Organogenesis Holdings Inc's reported EPS for the quarter
was 4
cents​.
    * The mean earnings estimate of analysts had fallen by
about 16.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Organogenesis Holdings Inc shares had risen by 11.4% this
quarter and gained 37.5% so far this year.
    * The company reported quarterly net income of $5.32
million.
    * Wall Street's median 12-month price target for
Organogenesis
Holdings Inc is $7.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 9 at 09:47 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      0.03           0.04           Beat
 Mar. 31 2023      -0.02          -0.02          Met
 Dec. 31 2022      0.05           0.06           Beat
 Sep. 30 2022      0.06           0.00           Missed